A disease outbreak news report from WHO: Nipah virus infection - Bangladesh. Excerpt:
Situation at a Glance
Outbreaks of Nipah virus (NiV) infection are seasonal in Bangladesh, with cases usually occurring annually between December and April corresponding with the harvesting and consumption of date palm sap. Since 1 January and as of 9 February 2024, two laboratory-confirmed cases of NiV have been reported from the Dhaka division of Bangladesh. Both cases have died.
WHO assesses the overall risk at the national levels to be moderate due to the severity of the disease, the limitation of treatment, the shared natural habitat of bats and zoonotic transmission partners, and the fact that there are no licensed vaccines to prevent NiV infection.
Description of the Situation
On 30 January and 7 February 2024, the Bangladesh National Focal Point (NFP) for the International Health Regulations (IHR) notified the World Health Organization (WHO) of two epidemiologically unlinked cases of NiV infection.
First case confirmed on 21 January 2024
The first patient is a 38-year-old male from Manikganj district, Dhaka division. The patient developed a fever followed by respiratory distress, restlessness, and insomnia on 11 January 2024 and was admitted to a local hospital on 16 January. He was transferred to the intensive care unit of a hospital in Dhaka City on 18 January where he was intubated due to worsening of symptoms.
On 21 January, blood and throat samples were collected and the patient tested positive by reverse transcription polymerase chain reaction (RT-PCR) for NiV RNA from the throat sample and by enzyme-linked immunosorbent assay (ELISA) for anti-NiV Immunoglobulin M (IgM) from serum. On 27 January, the case was transferred to another hospital in Dhaka city, where he died on 28 January.
The case had a history of consuming raw date palm sap on 31 December 2023. As of 30 January 2024, a total of 91 contacts had been identified, including 11 family members, 20 from the community, and 60 healthcare personnel from different hospitals. However, none of the contacts tested positive for NiV by PCR or anti-NiV IgM by ELISA.
Second case confirmed on 31 January 2024
The second patient is a three-year-old female from Shariatpur district, Dhaka division. The patient visited a healthcare facility on 30 January 2024 with a two-day history of fever, altered consciousnesses, and seizures. The case was diagnosed with encephalitis and shock and was transferred to the isolation ward of another hospital in Dhaka city on the same day. Blood and throat samples were collected on 30 January and on 31 January, the case was laboratory-confirmed with NiV infection by RT-PCR for NiV RNA from the throat sample and by ELISA for anti-NiV IgM from serum and died on the same day.
The case had a history of regularly consuming fresh raw date palm sap. As of 7 February 2024, 67 contacts were identified, including three family members, 21 from the community and 46 healthcare personnel from different hospitals. All identified contacts tested negative for NiV by PCR or anti-NiV IgM by ELISA.
Since the report of the first case in 2001, human infections have been reported almost every year, with case fatality rate varying between 25% (in 2009) and 92% (in 2005). Clusters of cases are mainly reported in the country’s central and northwest districts.
Recent Comments